Teva stock soars on positive Phase 2b study results
Investing.com — Shares of Teva Pharmaceutical Industries Ltd. (NYSE:TEVA) surged 17% following the announcement of successful Phase 2b study results...
Read moreInvesting.com — Shares of Teva Pharmaceutical Industries Ltd. (NYSE:TEVA) surged 17% following the announcement of successful Phase 2b study results...
Read moreInvesting.com — HSBC said the recent stalling of the post-election rally in risk assets and weaker U.S. equity breadth do not...
Read moreInvesting.com — Top executives from the digital asset industry, including Crypto.com’s CEO Kris Marszalek, have been meeting with President-elect Donald...
Read moreInvesting.com — The Biden administration has pledged a record $15 billion loan to the Pacific Gas and Electric Company (PG&E...
Read moreInvesting.com — Wedbush forecasts a 25% surge in technology stocks in 2025, driven by the continuing AI boom. The investment...
Read moreCopyright © 2024 Modernbusinesspost.com. All Rights Reserved.